Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
J Med Vasc ; 43(4): 255-261, 2018 Jul.
Article in French | MEDLINE | ID: mdl-29981734

ABSTRACT

Lower extremity peripheral artery disease is a frequent disease. Arterial Doppler waveforms analysis is a key element in vascular medicine, especially to diagnose lower peripheral artery disease. Although Doppler waveforms are often used, descriptions are highly heterogeneous. This review presents the simplified Saint-Bonnet classification that is tought to vascular medicine residents in order to homogenize arterial flow description.


Subject(s)
Leg/blood supply , Peripheral Arterial Disease/physiopathology , Ultrasonography, Doppler, Pulsed , Aneurysm, False/physiopathology , Arteriovenous Fistula/physiopathology , Classification , Doppler Effect , Humans , Plaque, Atherosclerotic/physiopathology , Pulsatile Flow
2.
J Mal Vasc ; 40(3): 200-5, 2015 May.
Article in French | MEDLINE | ID: mdl-25790900

ABSTRACT

We report a case of a 76-year-old woman with isolated unilateral Raynaud phenomenon revealing giant-cell arteritis with diffuse arterial lesions and bilateral renal artery stenosis. Doppler ultrasonography showed bilateral stenosis of the subclavian and axillary arteries. Angio-CT PET enlightened diffuse arterial lesions, mainly involving the aorta and the brachial and femoral arteries as well as bilateral renal ostial stenosis with right kidney ischemia. Diagnosis of giant-cell arteritis was made on the temporal artery biopsy. Corticosteroid therapy led to rapid clinical and radiological improvement. Clinical manifestations of giant-cell arteritis may be atypical. Diffuse arterial disease may exist in the absence of cephalic symptoms or significant inflammatory biological features. Ostial renal artery stenosis may induce potentially threatening renal ischemia.


Subject(s)
Giant Cell Arteritis/complications , Giant Cell Arteritis/diagnosis , Ischemia/complications , Kidney/blood supply , Raynaud Disease/etiology , Aged , Female , Humans
3.
Rheumatol Int ; 32(7): 2203-7, 2012 Jul.
Article in English | MEDLINE | ID: mdl-21785957

ABSTRACT

Hypothesizing a pathophysiological role of anti-topoisomerase I antibodies (anti-topo I) through autoantibody-dependent cell-mediated cytotoxicity (ADCC) and cytotoxic effectors expressing receptors for the Fc portion of IgG in systemic sclerosis (SSc), 267 SSc patients (56 with anti-topo I and 102 with anti-centromere antibodies (ACA)) were genotyped for the functional FCGR3A-V158F polymorphism. A descriptive analysis of patients according to their clinical and immunological status and FCGR3A-158 V/F genotypes was performed using multiple correspondence analysis. This descriptive analysis revealed an association between the FCGR3A-158 VV genotype and the presence of anti-topo I. By contrast, no relationship was found between FCGR3A polymorphism and the presence of ACA. SSc patients with anti-topo I appear to be more frequently homozygous for the high-affinity FcγRIIIA-coding allele, suggesting that some autoantibodies may be pathogenic through ADCC.


Subject(s)
DNA Topoisomerases, Type I/immunology , Genetic Association Studies , Receptors, IgG/genetics , Scleroderma, Systemic/genetics , Adult , Aged , Antibody-Dependent Cell Cytotoxicity/immunology , Autoantibodies/immunology , Centromere/immunology , Humans , Male , Middle Aged , Pilot Projects , Receptors, IgG/immunology , Scleroderma, Systemic/immunology
6.
Rev Med Interne ; 30(4): 345-8, 2009 Apr.
Article in French | MEDLINE | ID: mdl-19070944

ABSTRACT

INTRODUCTION: Cutaneous polyarteritis nodosa (CPAN) is an entity which needs to be acknowledged, since it can have a spontaneously adverse outcome. We report two cases of CPAN associated with Crohn's disease. CASE REPORTS: The first patient was suffering from Crohn's disease for 9 years when she was referred for a necrotic toe. A diagnosis of necrotizing angeitis was confirmed by histological examination of a skin biopsy. Despite systemic corticosteroids, the lesions became more severe, requiring immunosuppressive treatment. The second patient was a female patient referred with forefoot ischemia. Cutaneous histology confirmed the diagnosis of necrotizing angeitis that responded favourably to corticosteroid treatment. The patient had been diagnosed with Crohn's disease 2 months previously. CONCLUSION: CPAN differed from systemic PAN by the absence of visceral involvement. Its association with Crohn's disease, although uncommon, must be recognized as it affects treatment and monitoring.


Subject(s)
Crohn Disease/complications , Crohn Disease/pathology , Polyarteritis Nodosa/complications , Polyarteritis Nodosa/pathology , Adrenal Cortex Hormones/therapeutic use , Adult , Female , Humans , Immunosuppressive Agents/therapeutic use , Polyarteritis Nodosa/drug therapy , Skin Diseases/drug therapy , Skin Diseases/pathology , Treatment Outcome
9.
Arch Mal Coeur Vaiss ; 100(2): 149-52, 2007 Feb.
Article in French | MEDLINE | ID: mdl-17474502

ABSTRACT

Mitochondrial diseases may cause hypertrophic cardiomyopathy or, less commonly, dilated cardiomyopathy. The authors describe a case of a 46 year old woman with dilated cardiomyopathy associated with diabetes and deafness. This association is suggestive of the MIDD syndrome and the demonstration of metabolic abnormalities (raised serum lactic acid, abnormal lactate/pyruvate ratio) was compatible with a mitochondrial disease. This diagnosis was confirmed by finding an A3243G mutation of the mitochondrial DNA.


Subject(s)
Cardiomyopathy, Dilated/genetics , DNA, Mitochondrial/genetics , Deafness/genetics , Diabetes Mellitus/genetics , Female , Humans , Lactic Acid/blood , Middle Aged , Mutation , Pyruvic Acid/blood , Syndrome
10.
J Mal Vasc ; 31(5): 247-51, 2006 Dec.
Article in French | MEDLINE | ID: mdl-17202977

ABSTRACT

Elastic stockings and compression therapy are often considered as a major tool in the prevention and in the treatment of chronic venous insufficiency and of lymphedema. Nevertheless we must note that this therapeutic option is both underused and misused. We discuss the reasons for this paradox and the expected modes of action and pathophysiological benefits, and finally propose a prescription guide (indications, dosage, practice details) for a rational use of elastic stockings and compression therapy.


Subject(s)
Stockings, Compression , Venous Thrombosis/therapy , Humans , Reproducibility of Results , Stockings, Compression/statistics & numerical data
13.
Rev Med Interne ; 25 Suppl 4: S329-30, 2004 Dec.
Article in French | MEDLINE | ID: mdl-15582181
15.
J Mal Vasc ; 29(5): 243-8, 2004 Dec.
Article in French | MEDLINE | ID: mdl-15738835

ABSTRACT

Drug addiction which entails cardiovascular risks unknown or misknown to physicians, currently involves an increasing number of miscellaneous drugs, existing in manifold forms. There appears to be no bounds on the way of intake. All territories of the body may be affected with more or less severity. In young people, the cardiac, coronary, cerebral and peripheral vascular systems are generally involved. Two illicit drugs, cannabis and cocaine, showing a permanent increase in misuse, prevail. This drug addiction comes along with intercurrent pathologies which have their own vascular toxicity, especially HIV infection. Moreover, the advent of new illicit substances emphasizes the complexity of the clinical presentations. These complex situations have a real social and medical impact. We are currently in a phase of permanently increasing risk of cardiovascular complications. The pathophysiological mechanisms involved are intertwined and complicated by the frequent association of polytoxicomania or by the effects excipients added to these drugs: direct vascular toxicity, angeitis, arterial and venous thrombosis. Arsenic, a common component of these drugs, is also found in cigarettes; arsenic toxicity mainly affects the lower limbs. Treatment of these complications is non-specific; the ideal solution being weaning which, unfortunately in this peculiar population of patients, may entail serious complications due to the misuse of substitution products.


Subject(s)
Cardiovascular Diseases/etiology , Substance-Related Disorders/complications , Humans
16.
Occup Environ Med ; 59(8): 545-9, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12151611

ABSTRACT

AIMS: A case-control study was carried out between 1998 and 2000 to investigate the relation between systemic sclerosis and occupational exposure. METHODS: Eighty cases of systemic sclerosis admitted consecutively to the Department of Internal Medicine at the University Hospital of Tours from 1998 to 2000 were included. For each case, two age, gender, and smoking habits matched controls hospitalised during the same period in the same department were selected. A committee of experts was set up retrospectively to assess occupational exposure. Exposure to silica dust and organic solvents (such as trichlorethylene and other chlorinated solvents, and benzene and other aromatic solvents) was investigated using semiquantitative estimates of exposure. An exposure score was calculated for each subject based on probability, intensity, daily frequency, and duration of exposure for each period of employment. The final cumulative exposure score was obtained, taking into account all periods of employment. RESULTS: Significant associations with SS were observed for crystalline silica, trichlorethylene, chlorinated solvents, toluene, aromatic solvents, ketones, white spirit, epoxy resins, and welding fumes. Risk of SS was significantly associated with a high final cumulative exposure score of occupational exposure to crystalline silica, trichlorethylene, chlorinated solvents, welding fumes, and any types of solvents. CONCLUSION: Results confirm the influence of occupational risk factors in the occurrence of SS in both men and women. The link is not only with silica but also with other compounds such as solvents.


Subject(s)
Occupational Diseases/etiology , Scleroderma, Systemic/etiology , Case-Control Studies , Female , France , Humans , Male , Middle Aged , Occupational Exposure/adverse effects , Risk Factors , Silicon Dioxide/adverse effects , Socioeconomic Factors , Solvents/adverse effects
18.
J Mal Vasc ; 26(2): 135-41, 2001 Apr.
Article in French | MEDLINE | ID: mdl-11319421

ABSTRACT

The most severe stages of arteriopathy often involve multifocal macrovascular lesions leading to defective perfusion of the distal tissues and subsequent dysfunction of the microcirculation. Diabetic autonomous neuropathy facilitates and aggravates this endothelial dysfunction. Loss of vasomotricity, platelet and white cell activation, and cytokine release lead to an obstruction of the capillaries and alteration or even destruction of the endothelium. At this stage, the lesions are irreversible and tissue vitality is definitively compromised. The goal of medical treatment is to delay the development of dysfunction and subsequent destruction of the microcirculation before, during and after restoration of sufficient flow through the macrocirculation lesions by angioplasty and/or surgery. Extrapolating from in vitro and animal studies, two mediators, EDRF (NO) and prostacycline, could theoretically inactivate inappropriate activated cells and re-establish flow. Besides their vasodilator proprieties, NO and prostacycline have a synergetic inhibitory effect on platelet and leukocyte activation. The role of platelet antiaggregates and heparins in this stage of severe chronic ischemia remains to be determined. The relative failures of therapeutic drug trials conducted since the end of the eighties demonstrates the importance of intervening before the microcirulation disorders become too severe. Until new compounds are developed, therapeutic progress can be achieved by more precise and earlier detection of alterations in the microcirculation to enable optimal management of arteriopathy of the lower limbs with surgery or angioplasty.


Subject(s)
Diabetic Angiopathies/physiopathology , Diabetic Angiopathies/therapy , Microcirculation/physiopathology , Animals , Epoprostenol/physiology , Epoprostenol/therapeutic use , Humans , Nitric Oxide/physiology , Nitric Oxide/therapeutic use , Regional Blood Flow
19.
Rev Pneumol Clin ; 56(4): 265-8, 2000 Sep.
Article in French | MEDLINE | ID: mdl-11033535

ABSTRACT

A 75-year-old woman followed for Wegener's disease was hospitalized for pleural effusion. The clinical presentation and cytology of the pleural fluid suggested the diagnosis of purulent pleurisy in this immunodepressed patient. The final diagnosis was a pleural involvement of Wegener's disease, a rarely described localization, as proven by the typical pathology findings.


Subject(s)
Granulomatosis with Polyangiitis/diagnosis , Pleurisy/diagnosis , Acute Disease , Aged , Biopsy , Bronchi/pathology , Diagnosis, Differential , Female , Granulomatosis with Polyangiitis/diagnostic imaging , Granulomatosis with Polyangiitis/pathology , Humans , Pleurisy/diagnostic imaging , Radiography, Thoracic , Tomography, X-Ray Computed
20.
Presse Med ; 29(13): 709-16, 2000 Apr 08.
Article in French | MEDLINE | ID: mdl-10797825

ABSTRACT

RECOGNIZED EFFICACY: Platelet antiaggregats have been used with success for more than twenty years in industrialized countries, participating in reducing the number of complications of atherothrombosis. New compounds have appeared on the market over the last 3 years. CLOPIDOGREL: Clopidogrel is a thienopyridine similar to ticlopidine but with less toxicity, particularly hematological toxicity. Compared with aspirin for secondary prevention of atherothrombotic events in high risk patients, clopidogrel provides a significant 8.7% (p < 0.043) reduction in the relative risk of severe complications: myocardial infarction, ischemic stroke, death due to vascular cause. The most remarkable benefit is obtained in patients with atheromatous arteriopathy of the lower limbs: 23.8% reduction in relative risk. STENT AFTER ANGIOPLASTY: A combination regimen using aspirin and ticlopidine the month following stent implantation has allowed a very significant reduction in acute (within 24 hours) and subacute (within 30 days) coronary occlusions. Currently the aspirin-clopidogrel combination tends to be used instead of the aspirin-ticlopidine combination due to the lower hematological risk for a similar effect. GPIIBIIIA INHIBITORS: Injectable GPIIbIIIa inhibitors have changed management of the acute phase of coronary artery disease. Among these compounds, abciximab has the most extensively proven efficacy. It is mainly indicated for severe forms of coronary angioplasty with or without stent insertion. It provides a significant short-term and long-term reduction in severe events (myocardial infarction + death + revascularization). Oral formulations of GPIIbIIIa can be used to maintain and/or amplify the benefits obtained with injectable formulations. They are not currently available on the market. ASPIRIN: Due to its very low cost and low side-effect profile, aspirin plays an essential role in most indications where it remains the most widely used first-line platelet anti aggregate.


Subject(s)
Platelet Aggregation Inhibitors/therapeutic use , Thrombosis/complications , Thrombosis/prevention & control , Vascular Diseases/prevention & control , Aspirin/therapeutic use , Clinical Trials as Topic , Clopidogrel , Humans , Risk Factors , Ticlopidine/analogs & derivatives , Ticlopidine/therapeutic use , Vascular Diseases/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...